Asperg, Germany

Michaela Strotbek

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2020-2023

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Michaela Strotbek: Innovator in Cell Culture Technology

Introduction

Michaela Strotbek is an accomplished inventor based in Asperg, Germany, with a notable portfolio of patents focusing on advancements in cell culture technology. With a total of three patents, her work significantly contributes to the field of biopharmaceutical production.

Latest Patents

Strotbek's latest innovations include two prominent patents. The first patent, titled "Mammalian cells for producing a secreted protein," explores the downregulation of activating transcription factor 6 beta (ATF6B) and the combination of ceramide synthase 2 (CERS2) with TBC1 domain family member 20 (TBC1D20) proteins. This research aims to enhance the secretion pathways in mammalian cells, leading to improved yields of therapeutic proteins.

The second patent, "Cell engineering using microRNAs," focuses on engineered host cell lines with specific RNA sequences that significantly alter growth characteristics and secretion capabilities. This invention has the potential to streamline the production of recombinant biopharmaceutical products.

Career Highlights

Michaela Strotbek is currently employed at Boehringer Ingelheim International GmbH, a global leader in biopharmaceuticals. Her role leverages her expertise in cell culture technology to drive innovations aimed at optimizing production processes for therapeutic proteins.

Collaborations

In her career, Strotbek has worked alongside esteemed colleagues such as Angelika Hausser and Monilola Olayioye. These collaborations underscore the strong team dynamics that foster innovative research and development within Boehringer Ingelheim.

Conclusion

Michaela Strotbek exemplifies the spirit of innovation in cell culture technology, with her patents positioned to make a significant impact on the biopharmaceutical industry. Her contributions not only enhance production methods but also pave the way for improved therapeutic options in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…